BCL2 and cancer: NETs have been reported to play dual roles in tumor progression, acting as both pro-tumorigenic and anti-tumorigenic factors depending on the context.41 Previous studies have shown that NETs can promote tumor progression by fostering an inflammatory microenvironment, enhancing cancer cell migration, and shielding tumor cells from immune clearance.41 However, our results indicate an anti-tumorigenic role of NETs in the regression of GCMN following BCL2 inhibition.